GGrantIndex
Sort

64,565 grants matching drug discovery

CENTER OF EXCELLENCE FOR PROSTATE CANCER RESEARCH, EDUCATION AND COMMUNITY SERVIC

$1,120,885
Shafiq A Khan · Clark Atlanta University · P20 · FY2009 · MD

Developing Teixobactin for Respiratory Infections

$1,120,776
Dallas Hughes · Novobiotic Pharmaceuticals, Llc · R01 · FY2025 · AI

Identifying the origins of resilience through human single cell molecular networks, then testing them in diverse, resilient, human IPS lines

$1,120,761
Christopher A. Gaiteri · Rush University Medical Center · R01 · FY2019 · AG

Human Cardio-Pulmonary System on a Chip

$1,120,436
Kevin Kit Parker · Harvard Medical School · UH2 · FY2012 · TR

Biomolecular Structure and Dynamics

$1,120,200
Bruce E Bowler · University Of Montana · P30 · FY2021 · GM

Atlas of efflux and permeation determinants to advance antibacterial therapeutic discovery

$1,120,070
Helen I. Zgurskaya · University Of Oklahoma · R01 · FY2025 · AI

Kidney Therapeutics: Translating Discoveries into Prevention, Treatment and Cures for Kidney Diseases

$1,120,048
Susan E Quaggin · Northwestern University At Chicago · P30 · FY2022 · DK

Microparticle Therapy for Cerebral Amyloid Angiopathy

$1,119,539
Wolff M. Kirsch · Karamedica, Inc. · R44 · FY2021 · AG

Amyloid Beta Oligomer Induction of Alzheimer Disease in Nonhuman Primates

$1,119,343
Michael R Weed · Virscio, Inc. · R44 · FY2020 · AG

Pathogenesis and treatment of NOMID, DIRA and other autoinflammatory diseases

$1,119,036
Raphaela Goldbach-Mansky · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2011 · AR

SBIR Phase II: Chiral Polymers for Pharmaceutical Purification

$1,118,937
Stephen M Jaffe · Material Methods · · FY2006 · TIP

Human Trial of Allosteric Modulator Alpha7 Nicotinic Receptors in Schizophrenia

$1,118,298
Jeffrey A Lieberman · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · U01 · FY2015 · MH

Refanalin for lung preservation and transplantation

$1,117,921
Prakash Narayan · Angion Biomedica Corporation · R44 · FY2009 · HL

Development Of Theoretical Methods For Studying Biological Macromolecules

$1,117,834
Bernard R Brooks · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL

Xenobiotic receptors

$1,117,669
Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Cancer Center Support Grant

$1,117,647
Timothy L Ratliff · Purdue University · P30 · FY2013 · CA

A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform

$1,117,537
Shawn Hingtgen · Univ Of North Carolina Chapel Hill · U01 · FY2024 · TR

Center for Targeted Therapeutics

$1,117,500
Hippokratis Kiaris · University Of South Carolina At Columbia · P30 · FY2024 · GM

Center for Targeted Therapeutics

$1,117,500
Hippokratis Kiaris · University Of South Carolina At Columbia · P30 · FY2025 · GM

DCTD Synthetic Chemistry

$1,117,455
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2013 · CA

Tumor Plasticity

$1,117,200
Dario C. Altieri · Wistar Institute · R35 · FY2023 · CA

Tumor Plasticity

$1,117,200
Dario C. Altieri · Wistar Institute · R35 · FY2022 · CA

HIV-1 RNase H as a Therapeutic Target

$1,117,190
Stuart F. J. Le Grice · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Structure/Function Correlations Over Binuclear Non-Heme Iron and Related Enzymes

$1,117,078
Edward I Solomon · Stanford University · · FY2014 · BIO

NATURAL PRODUCT LEADS FOR NEW DRUG DISCOVERY AGAINST LEISHMANIASIS

$1,116,816
The University Of Mississippi · · FY2009 · Department of Defense